Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Comment by righand2on Jun 24, 2017 11:35pm
228 Views
Post# 26402034

RE:RE:RE:RE:RE:Need Catalyst

RE:RE:RE:RE:RE:Need Catalyst
LucasKnight wrote: Can't argue with righand2 there. Absolutely accurate in his assessment.




Well, I did leave out the GHA. I have to wonder if they might not wait until they get a better handle on the deliverability of their wells before committing to a definite amount of gas. If they have to sign a take-or-pay agreement, and fail to deliver the contracted amounts, that would be a double hit to the bottom line, less gas to deliver and a penalty as well. I hope they err on the side of caution in that regard.

But, if the recompletions prove the botched wells are still good, and the next two operated wells, plus the non-operated wells, are also economic on average, they should have the info needed to pull the trigger on a GHA. JMO
Bullboard Posts